Article16 Jul 2025Discover the science behind Tolebrutinib: a BTK inhibitor designed to slow MS disability progression by modulating adaptive and innate immunity Learn more
Article20 May 2025Thalamic atrophy as a new biomarker of MS? The predictive value and how to use in clinical practice Learn more